Biological Activity of the Receptor for Macrophage Colony-stimulating Factor in the Human Endometrial Cancer Cell Line, Ishikawa

Overview

Journal Br J Cancer

Specialty Oncology

Date 1996 Mar 1

PMID 8605095

Authors

S Takeda

W P Soutter

N J Dibb

J O White

Affiliations

Soon will be listed here.

Abstract

Previously we found that the Ishikawa endometrial cancer cell line expresses macrophage colony-stimulating factor (M-CSF) and c-fms transcripts and that its proliferation is enhanced by the addition of recombinant M-CSF. This suggested that Ishikawa cells are constitutively stimulated by M-CSF. In support of this we now show that Ishikawa cells secrete M-CSF and that known stimulators of M-CSF production increase the amount detected in Ishikawa cell conditioned medium. Using retroviral infections to introduce and express exogenous c-fms genes in Ishikawa cells we also demonstrate proliferation to be partially inhibited by a dominant negative, mutant c-fms gene, yet enhanced approximately 3-fold by a normal c-fms gene, under conditions in which the only source of M-CSF was that produced by the cells. The data provide evidence for the existence of an active M-CSF/receptor loop in these endometrial cancer cells and suggests the possibility of such activity in tumours of the endometrium and ovary that aberrantly express M-CSF and fms genes.

References

Arceci R, Shanahan F, Stanley E, Pollard J . Temporal expression and location of colony-stimulating factor 1 (CSF-1) and its receptor in the female reproductive tract are consistent with CSF-1-regulated placental development. Proc Natl Acad Sci U S A. 1989; 86(22):8818-22. PMC: 298381. DOI: 10.1073/pnas.86.22.8818. View

Downing J, Roussel M, Sherr C . Ligand and protein kinase C downmodulate the colony-stimulating factor 1 receptor by independent mechanisms. Mol Cell Biol. 1989; 9(7):2890-6. PMC: 362755. DOI: 10.1128/mcb.9.7.2890-2896.1989. View

Dibb N, Green S, Ralph P . Expression of v-fms and c-fms in the hemopoietic cell line FDC-P1. Growth Factors. 1990; 2(4):301-11. View

Kacinski B, Chambers S, Stanley E, Carter D, Tseng P, Scata K . The cytokine CSF-1 (M-CSF) expressed by endometrial carcinomas in vivo and in vitro, may also be a circulating tumor marker of neoplastic disease activity in endometrial carcinoma patients. Int J Radiat Oncol Biol Phys. 1990; 19(3):619-26. DOI: 10.1016/0360-3016(90)90488-6. View

Baiocchi G, Kavanagh J, Talpaz M, Wharton J, Gutterman J, Kurzrock R . Expression of the macrophage colony-stimulating factor and its receptor in gynecologic malignancies. Cancer. 1991; 67(4):990-6. DOI: 10.1002/1097-0142(19910215)67:4<990::aid-cncr2820670422>3.0.co;2-8. View

Kashles O, Yarden Y, Fischer R, Ullrich A, Schlessinger J . A dominant negative mutation suppresses the function of normal epidermal growth factor receptors by heterodimerization. Mol Cell Biol. 1991; 11(3):1454-63. PMC: 369423. DOI: 10.1128/mcb.11.3.1454-1463.1991. View

Kauma S, Aukerman S, Eierman D, Turner T . Colony-stimulating factor-1 and c-fms expression in human endometrial tissues and placenta during the menstrual cycle and early pregnancy. J Clin Endocrinol Metab. 1991; 73(4):746-51. DOI: 10.1210/jcem-73-4-746. View

Yamada H, Iwase S, Mohri M, Kufe D . Involvement of a nuclear factor-kappa B-like protein in induction of the macrophage colony-stimulating factor gene by tumor necrosis factor. Blood. 1991; 78(8):1988-95. View

Pollard J . Lymphohematopoietic cytokines in the female reproductive tract. Curr Opin Immunol. 1991; 3(5):772-7. DOI: 10.1016/0952-7915(91)90112-e. View

10.

Pampfer S, Daiter E, Barad D, Pollard J . Expression of the colony-stimulating factor-1 receptor (c-fms proto-oncogene product) in the human uterus and placenta. Biol Reprod. 1992; 46(1):48-57. DOI: 10.1095/biolreprod46.1.48. View

11.

Daiter E, Pampfer S, Yeung Y, Barad D, Stanley E, Pollard J . Expression of colony-stimulating factor-1 in the human uterus and placenta. J Clin Endocrinol Metab. 1992; 74(4):850-8. DOI: 10.1210/jcem.74.4.1548350. View

12.

Croxtall J, Pollard J, Carey F, Forder R, White J . Colony stimulating factor-1 stimulates Ishikawa cell proliferation and lipocortin II synthesis. J Steroid Biochem Mol Biol. 1992; 42(2):121-9. DOI: 10.1016/0960-0760(92)90020-j. View

13.

Filderman A, Bruckner A, Kacinski B, Deng N, Remold H . Macrophage colony-stimulating factor (CSF-1) enhances invasiveness in CSF-1 receptor-positive carcinoma cell lines. Cancer Res. 1992; 52(13):3661-6. View

14.

Reith A, Ellis C, Maroc N, Pawson T, Bernstein A, Dubreuil P . 'W' mutant forms of the Fms receptor tyrosine kinase act in a dominant manner to suppress CSF-1 dependent cellular transformation. Oncogene. 1993; 8(1):45-53. View

15.

Jokhi P, Chumbley G, King A, Gardner L, Loke Y . Expression of the colony stimulating factor-1 receptor (c-fms product) by cells at the human uteroplacental interface. Lab Invest. 1993; 68(3):308-20. View

16.

Sasaki H, Nishii H, Takahashi H, Tada A, Furusato M, Terashima Y . Mutation of the Ki-ras protooncogene in human endometrial hyperplasia and carcinoma. Cancer Res. 1993; 53(8):1906-10. View

17.

Yue X, Favot P, DUNN T, Cassady A, Hume D . Expression of mRNA encoding the macrophage colony-stimulating factor receptor (c-fms) is controlled by a constitutive promoter and tissue-specific transcription elongation. Mol Cell Biol. 1993; 13(6):3191-201. PMC: 359760. DOI: 10.1128/mcb.13.6.3191-3201.1993. View

18.

Leiserowitz G, Harris S, Subramaniam M, Keeney G, Podratz K, Spelsberg T . The proto-oncogene c-fms is overexpressed in endometrial cancer. Gynecol Oncol. 1993; 49(2):190-6. DOI: 10.1006/gyno.1993.1106. View

19.

Parhami F, Fang Z, Fogelman A, Andalibi A, Territo M, Berliner J . Minimally modified low density lipoprotein-induced inflammatory responses in endothelial cells are mediated by cyclic adenosine monophosphate. J Clin Invest. 1993; 92(1):471-8. PMC: 293634. DOI: 10.1172/JCI116590. View

20.

Baker D, Glover H, Dibb N . Synergy between SCF or M-CSF with IL-3 or GM-CSF in FDC-P1 cells: a sensitive assay of transforming mutations of c-fms. Leukemia. 1994; 8(1):141-50. View